Experimental cures are often the last hope for dying patients in the U. K. health system. Thanks to the British government, however, many sick Britons will soon have their last hopes dashed.
Why? Pharmaceutical companies from around the world have been scaling back clinical research in the United Kingdom, largely because of government parsimony. And British citizens have paid the price.
Read more about this distressing development here:
British system discourages availability of new drugs
With health care reform in America at the top of the agenda this election season, it’s more important than ever that we be aware of the dangers of government- run health care. America should avoid Britain’s mistakes and make sure we keep the interests — and hopes — of patients first in our pursuit of reform.